Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
97.86
+1.40 (1.45%)
Aug 13, 2025, 4:00 PM - Market closed

Rhythm Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-183.1-260.6-184.68-181.12-69.61-134
Upgrade
Depreciation & Amortization
1.531.561.761.671.160.69
Upgrade
Loss (Gain) From Sale of Investments
-7.57-8.17-9.84-1.27--
Upgrade
Stock-Based Compensation
50.339.6832.5519.8320.817.46
Upgrade
Other Operating Activities
19.59103.0719.244.87-100.25-0.23
Upgrade
Change in Accounts Receivable
-8.06-3.65-8.64-5.2-1.25-
Upgrade
Change in Inventory
-6.84-10.12-5.71-2.81-0.01-
Upgrade
Change in Accounts Payable
32.3121.9214.771.5418.31-6.45
Upgrade
Change in Unearned Revenue
-1.29--0.15-6.61--
Upgrade
Change in Other Net Operating Assets
-4.62.424.53-4.34-15.150.55
Upgrade
Operating Cash Flow
-107.72-113.88-136.16-173.43-146-121.98
Upgrade
Capital Expenditures
---0.05-0.28-0.43-0.21
Upgrade
Sale (Purchase) of Intangibles
-0.5-40.5-5.67-7-
Upgrade
Investment in Securities
9.69-7.670.0532.31-163.73158.75
Upgrade
Other Investing Activities
----495-
Upgrade
Investing Cash Flow
9.19-48.17-5.6728.03-62.16158.53
Upgrade
Issuance of Common Stock
88.5256.3957.4141.49166.482.01
Upgrade
Other Financing Activities
-16.09-416.9772.34--
Upgrade
Financing Cash Flow
72.43191.2474.37213.83166.482.01
Upgrade
Foreign Exchange Rate Adjustments
0.090-0.14---
Upgrade
Net Cash Flow
-26.0229.19-67.668.43-41.6838.56
Upgrade
Free Cash Flow
-107.72-113.88-136.2-173.71-146.44-122.19
Upgrade
Free Cash Flow Margin
-68.93%-87.51%-175.91%-734.87%-4642.90%-
Upgrade
Free Cash Flow Per Share
-1.73-1.87-2.36-3.33-2.95-2.77
Upgrade
Levered Free Cash Flow
-33.77-139.74-91.47-105.11-57.05-72.85
Upgrade
Unlevered Free Cash Flow
-19.72-126.86-82.79-101.86-57.05-72.85
Upgrade
Change in Working Capital
11.5310.584.81-17.411.9-5.9
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q